ASSET ACQUISITION (Details) $ in Millions |
Jan. 12, 2022
USD ($)
|
---|---|
Vyne product acquisition | |
Asset Acquisition | |
Upfront payment | $ 20.0 |
Additional payment | $ 5.0 |
Percentage of upfront payment received | 10.00% |
Vyne product acquisition | If annual sales reaches to $100 million | |
Asset Acquisition | |
Annual sales | $ 100.0 |
One-time payment | 10.0 |
Vyne product acquisition | If annual sales reaches to $200 million | |
Asset Acquisition | |
Annual sales | 200.0 |
One-time payment | $ 20.0 |
Minocycline products | |
Asset Acquisition | |
Business Acquisition interest | 4.00% |
Molecule Stabilizing Technology | |
Asset Acquisition | |
Business Acquisition interest | 1.50% |
X | ||||||||||
- Definition The amount of additional payment payable under the agreement. No definition available.
|
X | ||||||||||
- Definition The Annual Sales under Asset Purchase Agreement. No definition available.
|
X | ||||||||||
- Definition The amount of one-time payment payable under the agreement. No definition available.
|
X | ||||||||||
- Definition The amount of upfront fee payment payable under the agreement. No definition available.
|
X | ||||||||||
- Definition The percentage of upfront payment received. No definition available.
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Percentage of equity in the acquiree held by the acquirer immediately before the acquisition date in a business combination. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|